Log in
Enquire now
‌

US Patent 9777065 Anti-FZD10 monoclonal antibodies and methods for their use

Patent 9777065 was granted and assigned to Omeros (company) on October, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Omeros (company)
Omeros (company)
0
Current Assignee
Omeros (company)
Omeros (company)
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
97770650
Patent Inventor Names
Munehisa Yabuki0
Larry W. Tjoelker0
W. Jason Cummings0
Nancy Maizels0
Christi L. Wood0
Daniel S. Allison0
John B. Leppard0
Date of Patent
October 3, 2017
0
Patent Application Number
147896120
Date Filed
July 1, 2015
0
Patent Primary Examiner
‌
Jessica H Roark
0
Patent abstract

The present invention relates generally to anti-FZD10 antibodies and to methods of using anti-FZD10 antibodies. In particular, the anti-FZD10 antibodies described herein are useful for altering one or more of survival, replication, differentiation and epithelial-to-mesenchymal cell transition of embryonic stem cells and/or for the treatment of diseases, such as a variety of cancers, associated with expression of FZD10, including as stand-alone therapies and in combination therapies with other agents.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9777065 Anti-FZD10 monoclonal antibodies and methods for their use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.